These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 17786853)

  • 1. Do prodrugs deliver?
    Smith DA
    Curr Opin Drug Discov Devel; 2007 Sep; 10(5):550-9. PubMed ID: 17786853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. What should be considered on design of a colon-specific prodrug?
    Jung Y; Kim YM
    Expert Opin Drug Deliv; 2010 Feb; 7(2):245-58. PubMed ID: 20095945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Research of oral prodrugs: opportunities and challenges].
    Cao F; Ping QN; Chen J
    Yao Xue Xue Bao; 2008 Apr; 43(4):343-9. PubMed ID: 18664193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prodrugs: a challenge for the drug development.
    Zawilska JB; Wojcieszak J; Olejniczak AB
    Pharmacol Rep; 2013; 65(1):1-14. PubMed ID: 23563019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prodrug strategies to overcome poor water solubility.
    Stella VJ; Nti-Addae KW
    Adv Drug Deliv Rev; 2007 Jul; 59(7):677-94. PubMed ID: 17628203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prodrug strategies in anticancer chemotherapy.
    Kratz F; Müller IA; Ryppa C; Warnecke A
    ChemMedChem; 2008 Jan; 3(1):20-53. PubMed ID: 17963208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lessons learned from marketed and investigational prodrugs.
    Ettmayer P; Amidon GL; Clement B; Testa B
    J Med Chem; 2004 May; 47(10):2393-404. PubMed ID: 15115379
    [No Abstract]   [Full Text] [Related]  

  • 8. Design of anticancer prodrugs for reductive activation.
    Chen Y; Hu L
    Med Res Rev; 2009 Jan; 29(1):29-64. PubMed ID: 18688784
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current prodrug design for drug discovery.
    Hsieh PW; Hung CF; Fang JY
    Curr Pharm Des; 2009; 15(19):2236-50. PubMed ID: 19601825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poly(ethylene glycol) anticancer drug delivery systems.
    Greenwald RB
    P R Health Sci J; 2002 Jun; 21(2):113-21. PubMed ID: 12166021
    [No Abstract]   [Full Text] [Related]  

  • 11. EB1627: a soluble prodrug of the potent anticancer cyanoguanidine CHS828.
    Binderup E; Björkling F; Hjarnaa PV; Latini S; Baltzer B; Carlsen M; Binderup L
    Bioorg Med Chem Lett; 2005 May; 15(10):2491-4. PubMed ID: 15863303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prodrugs: design and clinical applications.
    Rautio J; Kumpulainen H; Heimbach T; Oliyai R; Oh D; Järvinen T; Savolainen J
    Nat Rev Drug Discov; 2008 Mar; 7(3):255-70. PubMed ID: 18219308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug delivery systems. 2. Camptothecin 20-O-poly(ethylene glycol) ester transport forms.
    Greenwald RB; Pendri A; Conover C; Gilbert C; Yang R; Xia J
    J Med Chem; 1996 May; 39(10):1938-40. PubMed ID: 8642549
    [No Abstract]   [Full Text] [Related]  

  • 14. Membrane transporter/receptor-targeted prodrug design: strategies for human and veterinary drug development.
    Majumdar S; Duvvuri S; Mitra AK
    Adv Drug Deliv Rev; 2004 Jun; 56(10):1437-52. PubMed ID: 15191791
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical studies of dendrimer prodrugs.
    Kojima C
    Expert Opin Drug Metab Toxicol; 2015; 11(8):1303-15. PubMed ID: 26028253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A chemical adaptor system designed to link a tumor-targeting device with a prodrug and an enzymatic trigger.
    Gopin A; Pessah N; Shamis M; Rader C; Shabat D
    Angew Chem Int Ed Engl; 2003 Jan; 42(3):327-32. PubMed ID: 12548691
    [No Abstract]   [Full Text] [Related]  

  • 17. Oral delivery of anticancer drugs II: the prodrug strategy.
    Mazzaferro S; Bouchemal K; Ponchel G
    Drug Discov Today; 2013 Jan; 18(1-2):93-8. PubMed ID: 22960308
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and bioavailability evaluation of coumarin-based prodrug of meptazinol.
    Xie Q; Wang X; Wang X; Jiang Z; Qiu Z
    Bioorg Med Chem Lett; 2005 Nov; 15(22):4953-6. PubMed ID: 16154745
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody-directed enzyme prodrug therapy: a promising approach for a selective treatment of cancer based on prodrugs and monoclonal antibodies.
    Tietze LF; Krewer B
    Chem Biol Drug Des; 2009 Sep; 74(3):205-11. PubMed ID: 19660031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prodrugs--from serendipity to rational design.
    Huttunen KM; Raunio H; Rautio J
    Pharmacol Rev; 2011 Sep; 63(3):750-71. PubMed ID: 21737530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.